These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 30106883)
1. Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial. Valle-Cabrera R; Mendoza-Rodríguez Y; Robaina-García M; Ballesteros J; Cordero-Jiménez JR; Espinosa-Rodríguez NB; Sotolongo-Garcia Y; Lauria-Horner B; J Clin Psychopharmacol; 2018 Oct; 38(5):454-459. PubMed ID: 30106883 [TBL] [Abstract][Full Text] [Related]
2. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D; JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675 [TBL] [Abstract][Full Text] [Related]
4. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K; Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242 [TBL] [Abstract][Full Text] [Related]
5. Sertraline treatment of major depression in patients with acute MI or unstable angina. Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M; JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073 [TBL] [Abstract][Full Text] [Related]
6. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145 [TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial. Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. Lin CH; Lin SH; Jang FL J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699 [TBL] [Abstract][Full Text] [Related]
10. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial. Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437 [TBL] [Abstract][Full Text] [Related]
11. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323 [TBL] [Abstract][Full Text] [Related]
12. Sertraline treatment of co-occurring alcohol dependence and major depression. Kranzler HR; Mueller T; Cornelius J; Pettinati HM; Moak D; Martin PR; Anthenelli R; Brower KJ; O'Malley S; Mason BJ; Hasin D; Keller M J Clin Psychopharmacol; 2006 Feb; 26(1):13-20. PubMed ID: 16415699 [TBL] [Abstract][Full Text] [Related]
13. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study. Hsu JW; Su TP; Huang CY; Chen YS; Chou YH J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697 [TBL] [Abstract][Full Text] [Related]
14. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression. Ravindran AV; Guelfi JD; Lane RM; Cassano GB J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734 [TBL] [Abstract][Full Text] [Related]
15. Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial. Lin CH; Wang SH; Lane HY Int J Neuropsychopharmacol; 2022 Aug; 25(7):545-555. PubMed ID: 35023557 [TBL] [Abstract][Full Text] [Related]
16. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916 [TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study. Asnis GM; Bose A; Gommoll CP; Chen C; Greenberg WM J Clin Psychiatry; 2013 Mar; 74(3):242-8. PubMed ID: 23561229 [TBL] [Abstract][Full Text] [Related]
20. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study]. Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]